# Construction of Diagnosis and Treatment System for Primary Vitreoretinal Lymphoma

> **NCT05950490** · — · UNKNOWN · sponsor: **Peking Union Medical College Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Primary Vitreoretinal Lymphoma

## Interventions

- **DRUG:** Intravitreal injection of methotrexate

## Key facts

- **NCT ID:** NCT05950490
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-10-01
- **Primary completion:** 2024-12
- **Final completion:** 2025-09
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2023-07-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05950490

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05950490, "Construction of Diagnosis and Treatment System for Primary Vitreoretinal Lymphoma". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05950490. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*